Learn more

TRANSKARYOTIC THERAPIES INC

Overview
  • Total Patents
    236
About

TRANSKARYOTIC THERAPIES INC has a total of 236 patent applications. Its first patent ever was published in 1991. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are GENESIS RES & DEV CORP LTD, MOGAM BIOTECH RES INST and TAIGA BIOTECHNOLOGIES INC.

Patent filings per year

Chart showing TRANSKARYOTIC THERAPIES INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Treco Douglas A 126
#2 Selden Richard F 117
#3 Heartlein Michael W 106
#4 Borowski Marianne 34
#5 Kinoshita Carol M 29
#6 Williams Melanie D 25
#7 Treco Douglas 23
#8 Miller Allan M 22
#9 Mineau-Hanschke Rochelle 20
#10 Concino Michael F 16

Latest patents

Publication Filing date Title
WO2005069192A1 CRYSTAL STRUCTURE OF HUMAN α-GALACTOSIDASE
CN101444621A Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (FGE)
BR0309665A Treatment of alpha-galactosidase deficiency at
AU9340301A Therapy for alpha-galactosidase a deficiency
AU2002215389A1 Optimized messenger rna
AR034262A1 A COMPOSITION TO PROVIDE AN INJECTABLE FLUID MIXTURE, A EQUIPMENT, A METHOD FOR PREPARING A MIXTURE OF SUCH EQUIPMENT, AN APPARATUS FOR THE INTRODUCTION OF A MIXTURE IN A PATIENT
IL142258D0 A dna construct altering the expression of a targeted gene
IL149679D0 Nucleic acid construct and methods utilizing the same
ZA200005747B Genomic sequences upstream of the coding region of the IFN-Alpha2 gene for protein production and delivery.
CA2379971A1 Hybrid matrices and hybrid matrix mixtures
US6670178B1 In Vivo production and delivery of insulinotropin for gene therapy
US6692737B1 In vivo protein production and delivery system for gene therapy
US6569681B1 Methods of improving homologous recombination
AU5953699A DNA construct for effecting homologous recombination and uses thereof
US6419920B1 Hybrid matrix implants and explants
US6924365B1 Optimized messenger RNA
AU4884199A Hybrid matrix implants and explants
AU4734199A Transfection of vertebrate cells e.g. by homologous recombination
US6531124B1 In vivo production and delivery of insulinotropin for gene therapy
AU3788899A Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery